skip to main content

Lipid therapy monitoring — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

EasyCardiovascular TherapeuticsLipid therapy monitoringGPhC CRA

A 52-year-old man starts atorvastatin for primary prevention after QRISK3 assessment. Baseline ALT is within range. He asks what follow-up blood test is usually needed. What monitoring is required?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: A — Liver transaminases at around 3 months

Liver transaminases are commonly checked after statin initiation and later if clinically indicated. Patients should also report muscle symptoms. The other tests are unrelated to routine statin safety monitoring.

Reference: BNF; NICE CKS